Literature DB >> 6380025

Low dosage diethylcarbamazine administered by villagers for the control of timorian filariasis.

F Partono, A Soewarta, S Oemijati.   

Abstract

The results of mass treatment using low dosage diethylcarbamazine (DEC) in three small villages in West Flores, Indonesia, endemic for Brugia timori are described. DEC was distributed on a weekly basis by motivated persons in the community to nearly all villagers for 18 months. An educational programme was developed which focused on describing the relationship between microfilaraemia, vector and disease manifestations, the danger of repeated attacks of adenolymphangitis, and the efficiency of DEC in eliminating the parasites and attacks. During the consolidation phase motivated persons were assigned to treat promptly all cases with acute filariasis and to distribute DEC to all new residents. With this programme the microfilaria rates decreased to very low levels, even as detected by the use of membrane filtration techniques. The adenolymphangitis rates also decreased. An unexpected bonus was the cure of "elephantiasis" in many people. Mild side effects attributed to DEC were encountered only during the first few weeks of treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380025     DOI: 10.1016/0035-9203(84)90124-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  3 in total

1.  British Paediatric Association-Communicable Disease Surveillance Centre surveillance of haemolytic uraemic syndrome 1983-4.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

Review 2.  Strategies and tools for the control/elimination of lymphatic filariasis.

Authors:  E A Ottesen; B O Duke; M Karam; K Behbehani
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 3.  Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

Authors:  Philip J Budge; Carly Herbert; Britt J Andersen; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2018-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.